[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Grigoriadou et al., 2010 - Google Patents

Interleukin-1 as a genetic marker for periodontitis: review of the literature

Grigoriadou et al., 2010

View PDF
Document ID
5297677669018426076
Author
Grigoriadou M
Koutayas S
Madianos P
Strub J
Publication year
Publication venue
Quintessence international

External Links

Snippet

Periodontitis is considered to be a multifactorial disease. Studies have indicated that part of the clinical variability in periodontitis may be explained by genetic factors. Genes can affect the immunoinflammatory host response to bacterial challenge in the periodontal tissues by …
Continue reading at www.researchgate.net (PDF) (other versions)

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Hybridisation probes
    • C12Q1/6883Hybridisation probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Similar Documents

Publication Publication Date Title
Grigoriadou et al. Interleukin-1 as a genetic marker for periodontitis: review of the literature
Melo et al. Interleukin‐1β and interleukin‐6 expression and gene polymorphisms in subjects with peri‐implant disease
Cullinan et al. A longitudinal study of interleukin‐1 gene polymorphisms and periodontal disease in a general adult population
Patel et al. Estimation and comparison of salivary calcium, phosphorous, alkaline phosphatase and pH levels in periodontal health and disease: A cross-sectional biochemical study
Genco et al. Risk factors for periodontal disease
Joshipura et al. Aggressive periodontitis: A review
Yang et al. Non‐carious cervical lesions (NCCL s) in a random sampling community population and the association of NCCL s with occlusive wear
Khiste et al. Critical analysis of biomarkers in the current periodontal practice
Scapoli et al. Interleukin-6 gene polymorphism modulates the risk of periodontal diseases
Rakic et al. CD14 and TNFα single nucleotide polymorphisms are candidates for genetic biomarkers of peri-implantitis
Li et al. Quantitative evaluation of MMP-9 and TIMP-1 promoter methylation in chronic periodontitis
Tobón-Arroyave et al. Association study of Vitamin D receptor (VDR)-related genetic polymorphisms and their haplotypes with chronic periodontitis in Colombian population
Buchmann et al. PMN responses in chronic periodontal disease: evaluation by gingival crevicular fluid enzymes and elastase‐alpha‐1‐proteinase inhibitor complex
Rathod et al. Estimation of salivary and serum total sialic acid levels in periodontal health and disease
Yücel et al. Association of interleukin-1 beta (+ 3954) gene polymorphism and gingival crevicular fluid levels in patients with aggressive and chronic periodontitis
Ueno et al. Association between diabetes mellitus and oral health status in Japanese adults
Nieminen et al. Value of some laboratory and clinical measurements in the treatment plan for advanced periodontitis
Villa‐Correa et al. Influence of periodontal clinical status on salivary levels of glutathione reductase
Persson Site-based versus subject-based periodontal diagnosis.
Vandesteen et al. Peripheral blood leukocyte abnormalities and periodontal disease: a family study
Guan et al. Identifying periodontitis risk factors through a retrospective analysis of 80 cases
TW201102649A (en) Metabolites for oral health and uses thereof
Görgün et al. IL-13 gene polymorphisms (-1112 C/T and-1512 A/C) in patients with chronic and aggressive periodontitis: Effects on GCF and outcome of periodontal therapy
Waligóra et al. Salivary matrix metalloproteinase-9 (MMP-9) as a biomarker of periodontitis in pregnant patients with diabetes
Deppe et al. Are selected IL-1 polymorphisms and selected subgingival microorganisms significantly associated to periodontitis in type 2 diabetes patients? a clinical study